Saudi Pharmaceutical Industries and Medical Appliances "SPIMACO" has announced that its subsidiary, Arabian-Moroccan for Pharmaceutical Industry (Ipharma) has obtained the approval of Ipharma to increase its capital from 54,2% to 62,68% in the Initial Public Offering (IPO) that aims at doubling the company's capital from MAD 50 million to 100 million. The company said in a statement posted today on the Saudi financial market "TADAWUL" that the approval on Ipharma's capital increase came following a meeting of the company's board yesterday in the Moroccan city of Tangier.